Apollomics (APLM) Total Non-Current Liabilities (2021 - 2025)

Apollomics (APLM) reported Total Non-Current Liabilities of $3.6 million for Q4 2025, up 1183.64% quarter-over-quarter from -$330000.0 in Q4 2023.

Apollomics (APLM) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Apollomics (APLM) has 4 years of Total Non-Current Liabilities data on file, last reported at $3.6 million in Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $3.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (changed N/A YoY), and the FY2025 annual result was $3.6 million, up 3605.88% from the prior year.
  • Total Non-Current Liabilities rose to $3.6 million in Q4 2025 per APLM's latest filing, from -$330000.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $512.2 million in Q4 2022 and troughed at -$330000.0 in Q4 2023.
  • A 4-year average of $168.0 million and a median of $3.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 58.71% in 2022, then plunged 100.06% in 2023.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $322.7 million in 2021, then jumped by 58.71% to $512.2 million in 2022, then sank by 100.06% to -$330000.0 in 2023, then jumped by 1183.64% to $3.6 million in 2025.
  • Business Quant data shows APLM's Total Non-Current Liabilities at $3.6 million in Q4 2025, -$330000.0 in Q4 2023, and $1.5 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 11.03 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.26 Bn 94.26 Bn - 64.76 Mn
10 Apollomics 294.00 Mn 294.00 Mn - 3.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.58 Mn
Dec 31, 2023 -330,000.00
Jun 30, 2023 1.55 Mn
Dec 31, 2022 512.24 Mn
Dec 31, 2021 322.74 Mn